🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of the study is to evaluate long-term safety and tolera...
Status
Completed
Location
Prostate Oncology Specialists
Start Date
2001-07
Trial ID
NCT00127478
Treatments Being Tested
RATIONALE: There is emerging data to suggest that the optimal use of angiog...
Status
Terminated
Location
Central Georgia Hematology Oncology Associates, P.C.
Start Date
2003-05
Trial ID
NCT00653328
Treatments Being Tested
The main purpose of this study is to look at the effects (good or bad) that...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2001-12
Trial ID
NCT00181558
Treatments Being Tested
The study objective was to evaluate the effect of atrasentan compared with ...
Status
Terminated
Location
Multiple Locations
Start Date
2013-05-17
Trial ID
NCT01858532
Treatments Being Tested
The study aims to longitudinally capture the full spectrum of symptoms, tre...
Status
Recruiting
Location
Novartis Investigational site
Start Date
2025-03-04
Trial ID
NCT06952426
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Jonsson Comprehensive Cancer Center, UCLA
Start Date
2002-09
Trial ID
NCT00046943
Treatments Being Tested
The current prospective, non-interventional study (NIS) being conducted und...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-05-29
Trial ID
NCT07481084
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Mayo Clinic Scottsdale
Start Date
2003-07-14
Trial ID
NCT00039429
Treatments Being Tested
This study is being done to evaluate the safety and efficacy of atrasentan ...
Status
Completed
Location
Urology Centers Of Alabama
Start Date
2001-06
Trial ID
NCT00036556
Treatments Being Tested
Prospective, randomized, double-blind, placebo controlled, 12-week, multice...
Status
Completed
Location
Site Reference ID/Investigator# 62022
Start Date
2011-08
Trial ID
NCT01424319
Treatments Being Tested